- History and future of hepatitis B virus control in South Korea
-
Kim DY
- KMID: 2520845
- Clin Mol Hepatol.
- 2021 Oct;27(4):620-622.
- doi: 10.3350/cmh.2021.0277
-
- CITED
-
- Close
- SHARE
-
- Close
- Can hepatocellular carcinoma recurrence be prevented after liver transplantation?
-
Kim JM
- KMID: 2520839
- Clin Mol Hepatol.
- 2021 Oct;27(4):562-563.
- doi: 10.3350/cmh.2021.0276
-
- CITED
-
- Close
- SHARE
-
- Close
- Microwave thermosphere versus radiofrequency ablation for hepatocellular carcinoma: Are we approaching the time to end the debate?
-
Kim MD
- KMID: 2520838
- Clin Mol Hepatol.
- 2021 Oct;27(4):560-561.
- doi: 10.3350/cmh.2021.0279
-
- CITED
-
- Close
- SHARE
-
- Close
- Update on liver disease management during the pandemic of coronavirus disease 2019 (COVID-19): 2021 KASL guideline
-
Cho JY, Lee YS, Kim SS, Song DS, Lee JH, Kim JH, on behalf of the Korean Association for the Study of the Liver
- KMID: 2520834
- Clin Mol Hepatol.
- 2021 Oct;27(4):515-523.
- doi: 10.3350/cmh.2021.0293
-
- CITED
-
- Close
- SHARE
-
- Close
- Impact of branched-chain amino acids and frailty on the management of lenvatinib-related fatigue in patients with hepatocellular carcinoma
-
Shimose S, Koya S, Kawaguchi T, Hirota K, Yoshio S, Niizeki T, Matsuse H, Torimura T
- KMID: 2520844
- Clin Mol Hepatol.
- 2021 Oct;27(4):616-619.
- doi: 10.3350/cmh.2021.0258
-
- CITED
-
- Close
- SHARE
-
- Close
- Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis
-
Chun HS, Choe AR, Lee M, Cho Y, Kim HY, Yoo K, Kim TH
- KMID: 2520836
- Clin Mol Hepatol.
- 2021 Oct;27(4):535-552.
- doi: 10.3350/cmh.2021.0109
Although patients with cirrhosis are known to be in a state of “rebalance” in that pro- and anticoagulant factors increase the risk for both bleeding and thrombosis, the prevalence of... -
- CITED
-
- Close
- SHARE
-
- Close
- Recent advances in nonalcoholic fatty liver disease metabolomics
-
Kim HY
- KMID: 2520837
- Clin Mol Hepatol.
- 2021 Oct;27(4):553-559.
- doi: 10.3350/cmh.2021.0127
The clinical phenotypes of nonalcoholic fatty liver disease (NAFLD) encompass from simple steatosis to nonalcoholic steatohepatitis (NASH) with varying degrees of fibrosis or cirrhosis. Liver biopsy has been the standard... -
- CITED
-
- Close
- SHARE
-
- Close
- New next-generation microwave thermosphere ablation for small hepatocellular carcinoma
-
Tamai H, Okamura J
- KMID: 2520840
- Clin Mol Hepatol.
- 2021 Oct;27(4):564-574.
- doi: 10.3350/cmh.2021.0136
Background/Aims: In July 2017, the Emprint™ next-generation microwave ablation system using thermosphere technology (Covidien, Boulder, CO, USA) was approved for use in Japan. This system can produce a predictable spherical... -
- CITED
-
- Close
- SHARE
-
- Close
- Three heads are better than two: Hepatitis B core-related antigen as a new predictor of hepatitis B virus-related hepatocellular carcinoma
-
Wu JW, Kao JH, Tseng TC
- KMID: 2520835
- Clin Mol Hepatol.
- 2021 Oct;27(4):524-534.
- doi: 10.3350/cmh.2021.0012
Patients with chronic hepatitis B virus (HBV) infection are at risk of developing hepatocellular carcinoma (HCC), and serum markers reflecting viral replication are potential predictors for HCC development. Besides the... -
- CITED
-
- Close
- SHARE
-
- Close
- Sofosbuvir/velpatasvir plus ribavirin for Child-Pugh B and Child-Pugh C hepatitis C virus-related cirrhosis
-
Liu CH, Chen CY, Su WW, Liu CJ, Lo CC, Huang KJ, Chen JJ, Tseng KC, Chang CY, Peng CY, Shih YL, Huang CS, Kao WY, Yang SS, Tsai MC, Wu JH, Chen PY, Su PY, Hwang JJ, Fang YJ, Lee PL, Tseng CW, Lee FJ, Lai HC, Hsieh TY, Chang CC, Chang CH, Huang YJ, Kao JH
- KMID: 2520841
- Clin Mol Hepatol.
- 2021 Oct;27(4):575-588.
- doi: 10.3350/cmh.2021.0155
Background/Aims: Real-world studies assessing the effectiveness and safety of sofosbuvir/velpatasvir (SOF/VEL) plus ribavirin (RBV) for Child-Pugh B/C hepatitis C virus (HCV)-related cirrhosis are limited. Methods: We included 107 patients with Child-Pugh... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of everolimus on survival after liver transplantation for hepatocellular carcinoma
-
Kang I, Lee JG, Choi SH, Kim HJ, Han DH, Choi GH, Kim MS, Choi JS, Kim SI, Joo DJ
- KMID: 2520842
- Clin Mol Hepatol.
- 2021 Oct;27(4):589-602.
- doi: 10.3350/cmh.2021.0038
Background/Aims: This study aimed to investigate whether everolimus (EVR) affects long-term survival after liver transplantation (LT) in patients with hepatocellular carcinoma (HCC). Methods: The data from 303 consecutive patients with HCC... -
- CITED
-
- Close
- SHARE
-
- Close
- Cost-effectiveness and long-term outcomes of liver transplantation using hepatitis B core antibody-positive grafts with hepatitis B immunoglobulin prophylaxis in Korea
-
Kim KD, Lee JE, Kim JM, Lee O, Hwang NY, Rhu J, Choi GS, Kim K, Joh JW
- KMID: 2520843
- Clin Mol Hepatol.
- 2021 Oct;27(4):603-615.
- doi: 10.3350/cmh.2021.0137
Background/Aims: Hepatitis B core antibody (anti-HBc)-positive donors are used as an extended donor pool, and current guidelines recommend the usage of nucleos(t)ide analogues (NAs) as prophylaxis for preventing de novo... -
- CITED
-
- Close
- SHARE
-
- Close
